Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography imaging

Endocrine ◽  
2010 ◽  
Vol 37 (1) ◽  
pp. 209-212 ◽  
Author(s):  
Mouhammed Amir Habra ◽  
Rodolfo Núñez ◽  
Hubert Chuang ◽  
Montserrat Ayala-Ramirez ◽  
Thereasa Rich ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Positron Emission Tomography ◽  
Glucose Consumption ◽  
Malignant Pheochromocytoma ◽  
Emission Tomography ◽  
Computed Tomography Imaging ◽  
Tomography Imaging ◽  
Positron Emission

scholarly journals Breast Metastasis Detected on Ga-68 DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Malignant Pheochromocytoma

2015 ◽  
Vol 14 (1) ◽  
pp. 69 ◽  
Author(s):  
BhagwantRai Mittal ◽  
RajinderKumar Basher ◽  
Anish Bhattacharya ◽  
RahulVithalrao Parghane ◽  
Rakhee Vatsa ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Positron Emission Tomography ◽  
Malignant Pheochromocytoma ◽  
Emission Tomography ◽  
Breast Metastasis ◽  
Computed Tomography Imaging ◽  
Tomography Imaging ◽  
Positron Emission

Increased F-18 FDG Uptake on Positron Emission Tomography/Computed Tomography Imaging Caused by Plantar Fibromatosis

2008 ◽  
Vol 33 (4) ◽  
pp. 280-281 ◽  
Author(s):  
Jennifer Scheler ◽  
Bhavya Rehani ◽  
Thomas Percy ◽  
Richard Pelstring ◽  
Ankur Bharija ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Positron Emission Tomography ◽  
Emission Tomography ◽  
Computed Tomography Imaging ◽  
Tomography Imaging ◽  
Fdg Uptake ◽  
Positron Emission ◽  
Plantar Fibromatosis

scholarly journals 18F-fluorideoxyglucose positron emission tomography/computed tomography imaging: Artifacts and pitfalls

2015 ◽  
Vol 68 (1-2) ◽  
pp. 41-48
Author(s):  
Jasna Mihailovic ◽  
Emil Matovina ◽  
Katarina Nikoletic
Keyword(s):  
Computed Tomography ◽  
Positron Emission Tomography ◽  
Healing Process ◽  
Emission Tomography ◽  
Benign Tumors ◽  
Positive Finding ◽  
Computed Tomography Imaging ◽  
Tomography Imaging ◽  
18F Fluorodeoxyglucose ◽  
Positron Emission

18F-fluorodeoxyglucose, being a radiolabeled glucose analogue, is a marker of glucose metabolism indicator. Since glucose uptake is increased in malignant tumors, its major application is in oncology. However, an increased 18F- fluorodeoxyglucose uptake is found in various benign tumors, granulomatous diseases, tuberculosis, inflammation, infection. A healing process may be interpreted as a false positive finding. In contrast, some types of renal cell cancers and lymphomas, neuroendocrine tumors, colonic mucinous adenocarcinomata, hepatocellular carcinomas, prostate cancer, and carcinoid tumors have low 18Ffluorodeoxyglucose avidity which may give a misleading false negative result. In addition, an increased 18F-fluorodeoxyglucose uptake in the bone marrow may be seen in oncologycal patients following various types of therapy. Besides the advantages of hybrid positron emission tomography-computed tomography imaging, this dual-modality scanning may produce their own specific artifacts due to different causes, such as metallic implants, respiratory motion, contrast medium and truncation. Proper patient preparation is required to minimize the potential artifactual uptake patterns that make reporting difficult. It is important to learn about proper quality control, imaging and reconstruction and to be familiar with potential artifacts and pitfalls for the accurate interpretation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography.

Sign in / Sign up

Export Citation Format

Share Document